Q3 2021 Holdings
Filed 2021-11-15 | 397 holdings | $19.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Conocophillips(COP) | COM | 20825C104 | $1.8M | 26,059 | 9.0% |
| Cubesmart(CUBE) | COM | 229663109 | $1.6M | 33,919 | 8.4% |
| Cousins Pptys Inc(CUZ) | COM NEW | 222795502 | $1.6M | 42,315 | 8.0% |
| Crown Castle Intl Corp New(CCI) | COM | 22822V101 | $1.4M | 8,075 | 7.1% |
| Barrick Gold Corp(ABX) | COM | 067901108 | $1.4M | 75,262 | 6.9% |
| DTE Energy Co(DTE) | COM | 233331107 | $1.3M | 12,058 | 6.8% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $566.0K | 2,073 | 2.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $518.0K | 2,745 | 2.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $482.0K | 1,328 | 2.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $428.0K | 5,544 | 2.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $425.0K | 7,865 | 2.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $404.0K | 28,090 | 2.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $362.0K | 7,849 | 1.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $348.0K | 9,723 | 1.8% |
| Crescent Cap BDC Inc(CCAP) | COM | 225655109 | $325.0K | 17,002 | 1.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $320.0K | 1,131 | 1.6% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $313.0K | 8,932 | 1.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $302.0K | 8,664 | 1.5% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $297.0K | 7,130 | 1.5% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $283.0K | 5,913 | 1.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $279.0K | 16,785 | 1.4% |
| DT Midstream Inc(DTM) | COMMON STOCK | 23345M107 | $279.0K | 6,030 | 1.4% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $260.0K | 3,526 | 1.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $252.0K | 1,581 | 1.3% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $245.0K | 47,350 | 1.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $236.0K | 11,225 | 1.2% |
| Alector Inc(ALEC) | COM | 014442107 | $229.0K | 10,039 | 1.2% |
| Codexis Inc(CDXS) | COM | 192005106 | $229.0K | 9,865 | 1.2% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $225.0K | 5,043 | 1.1% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $215.0K | 8,379 | 1.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $208.0K | 2,530 | 1.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $196.0K | 23,335 | 1.0% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $174.0K | 7,304 | 0.9% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $174.0K | 8,664 | 0.9% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $172.0K | 25,770 | 0.9% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $168.0K | 58,243 | 0.9% |
| Annexon Inc(ANNX) | COM | 03589W102 | $168.0K | 9,043 | 0.9% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $162.0K | 5,439 | 0.8% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $156.0K | 6,925 | 0.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $156.0K | 3,336 | 0.8% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $152.0K | 17,296 | 0.8% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $150.0K | 2,403 | 0.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $149.0K | 29,358 | 0.8% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $140.0K | 16,600 | 0.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $104.0K | 3,146 | 0.5% |
| Annovis BIO Inc(ANVS) | COM | 03615A108 | $76.0K | 2,387 | 0.4% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $38.0K | 28,694 | 0.2% |
| Cabot Oil & Gas Corp(CTRA) | COM | 127097103 | $2.2K | 98,843 | 0.0% |
| Innovative Indl Pptys Inc(IIPR) | COM | 45781V101 | $1.9K | 8,398 | 0.0% |
| Cyrusone Inc(CONE1EUR) | COM | 23283R100 | $1.8K | 22,719 | 0.0% |